Sale of Securities

X4 Pharmaceuticals, Inc Filed 2026-10-01 Acc 0001276750-26-000008

Documents 1

2026-10-08 8-K Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure
2026-10-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-10-05 4 Chief Financial Officer sold 11,767 shares at $2.86 ($33,658)
2026-10-01 144 Sale of Securities
2026-08-13 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…